27379201|t|Comparison of Individual Radiosensitivity to γ-Rays and Carbon Ions
27379201|a|Carbon ions are an up-and-coming ion species, currently being used in charged particle radiotherapy. As it is well established that there are considerable interindividual differences in radiosensitivity in the general population that can significantly influence clinical outcomes of radiotherapy, we evaluate the degree of these differences in the context of carbon ion therapy compared with conventional radiotherapy. In this study, we evaluate individual radiosensitivity following exposure to carbon-13 ions or γ-rays in peripheral blood lymphocytes of healthy individuals based on the frequency of ionizing radiation (IR)- induced DNA double strand breaks (DSBs) that was either misrepaired or left unrepaired to form chromosomal aberrations (CAs) (simply referred to here as DSBs for brevity). Levels of DSBs were estimated from the scoring of CAs visualized with telomere / centromere - fluorescence in situ hybridization (TC-FISH). We examine radiosensitivity at the dose of 2 Gy, a routinely administered dose during fractionated radiotherapy, and we determined that a wide range of DSBs were induced by the given dose among healthy individuals, with highly radiosensitive individuals harboring more IR - induced breaks in the genome than radioresistant individuals following exposure to the same dose. Furthermore, we determined the relative effectiveness of carbon irradiation in comparison to γ-irradiation in the induction of DSBs at each studied dose (isodose effect), a quality we term " relative dose effect " (RDE). This ratio is advantageous, as it allows for simple comparison of dose-response curves. At 2 Gy, carbon irradiation was three times more effective in inducing DSBs compared with γ-irradiation (RDE of 3); these results were confirmed using a second cytogenetic technique, multicolor-FISH. We also analyze radiosensitivity at other doses (0.2-15 Gy), to represent hypo - and hyperfractionation doses and determined that RDE is dose dependent: high ratios at low doses, and approaching 1 at high doses. These results could have clinical implications as IR-induced DNA damage and the ensuing CAs and genomic instability can have significant cellular consequences that could potentially have profound implications for long-term human health after IR exposure, such as the emergence of secondary cancers and other pathobiological conditions after radiotherapy.
27379201	0	10	Comparison	T052	C1707455
27379201	14	24	Individual	T098	C0027361
27379201	25	41	Radiosensitivity	T032	C0034537
27379201	45	51	γ-Rays	T070	C0017011
27379201	56	67	Carbon Ions	T196	C0596255
27379201	68	79	Carbon ions	T196	C0596255
27379201	101	112	ion species	T196	C0022023
27379201	138	167	charged particle radiotherapy	T061	C2985551
27379201	223	238	interindividual	T098	C0027361
27379201	239	250	differences	T080	C1705242
27379201	254	270	radiosensitivity	T032	C0034537
27379201	254	270	radiosensitivity	T032	C0034537
27379201	278	296	general population	T098	C0683971
27379201	330	347	clinical outcomes	T034	C0456984
27379201	351	363	radiotherapy	T061	C1522449
27379201	381	387	degree	T081	C0449286
27379201	397	408	differences	T080	C1705242
27379201	427	445	carbon ion therapy	T061	C3494442
27379201	460	472	conventional	T080	C0439858
27379201	473	485	radiotherapy	T061	C1522449
27379201	514	524	individual	T098	C0027361
27379201	525	541	radiosensitivity	T032	C0034537
27379201	552	563	exposure to	T080	C0332157
27379201	564	573	carbon-13	T197	C0729631
27379201	574	578	ions	T196	C0022023
27379201	582	588	γ-rays	T070	C0017011
27379201	592	620	peripheral blood lymphocytes	T025	C1518997
27379201	624	631	healthy	T080	C3898900
27379201	632	643	individuals	T098	C0027361
27379201	657	666	frequency	T079	C0439603
27379201	670	688	ionizing radiation	T070	C0034538
27379201	690	692	IR	T070	C0034538
27379201	695	702	induced	T169	C0205263
27379201	703	727	DNA double strand breaks	T049	C1511667
27379201	729	733	DSBs	T049	C1511667
27379201	790	813	chromosomal aberrations	T049	C0008625
27379201	815	818	CAs	T049	C0008625
27379201	848	852	DSBs	T049	C1511667
27379201	867	873	Levels	T080	C0441889
27379201	877	881	DSBs	T049	C1511667
27379201	906	913	scoring	T081	C0449820
27379201	917	920	CAs	T049	C0008625
27379201	937	945	telomere	T026	C0085187
27379201	948	958	centromere	T026	C0007709
27379201	961	995	fluorescence in situ hybridization	T063	C0162789
27379201	997	1004	TC-FISH	T063	C0162789
27379201	1018	1034	radiosensitivity	T032	C0034537
27379201	1042	1046	dose	T081	C4019308
27379201	1068	1080	administered	T169	C1621583
27379201	1081	1085	dose	T081	C4019308
27379201	1093	1118	fractionated radiotherapy	T061	C1522449
27379201	1159	1163	DSBs	T049	C1511667
27379201	1169	1176	induced	T169	C0205263
27379201	1184	1189	given	T169	C1621583
27379201	1190	1194	dose	T081	C4019308
27379201	1201	1208	healthy	T080	C3898900
27379201	1209	1220	individuals	T098	C0027361
27379201	1234	1248	radiosensitive	T169	C0332324
27379201	1249	1260	individuals	T098	C0027361
27379201	1276	1278	IR	T070	C0034538
27379201	1281	1288	induced	T169	C0205263
27379201	1289	1295	breaks	T080	C0443161
27379201	1303	1309	genome	T028	C0017428
27379201	1315	1329	radioresistant	T077	C3890377
27379201	1330	1341	individuals	T098	C0027361
27379201	1352	1363	exposure to	T037	C0015333
27379201	1373	1377	dose	T081	C4019308
27379201	1410	1432	relative effectiveness	T081	C3825732
27379201	1436	1442	carbon	T196	C0007009
27379201	1443	1454	irradiation	T061	C1522449
27379201	1472	1485	γ-irradiation	T061	C2985557
27379201	1493	1502	induction	T169	C0205263
27379201	1506	1510	DSBs	T049	C1511667
27379201	1527	1531	dose	T081	C4019308
27379201	1533	1540	isodose	T081	C1881277
27379201	1541	1547	effect	T080	C1280500
27379201	1570	1590	relative dose effect	UnknownType	C0683160
27379201	1594	1597	RDE	UnknownType	C0683160
27379201	1605	1610	ratio	T081	C0456603
27379201	1666	1686	dose-response curves	T081	C0683162
27379201	1697	1715	carbon irradiation	T061	C3494442
27379201	1737	1746	effective	T080	C1280519
27379201	1750	1758	inducing	T169	C0205263
27379201	1759	1763	DSBs	T049	C1511667
27379201	1778	1791	γ-irradiation	T061	C2985557
27379201	1793	1796	RDE	UnknownType	C0683160
27379201	1848	1869	cytogenetic technique	T063	C0752095
27379201	1871	1886	multicolor-FISH	T063	C0162789
27379201	1904	1920	radiosensitivity	T032	C0034537
27379201	1930	1935	doses	T081	C4019308
27379201	1962	1966	hypo	T061	C4042795
27379201	1973	1997	hyperfractionation doses	T081	C4019308
27379201	2018	2021	RDE	UnknownType	C0683160
27379201	2025	2039	dose dependent	T081	C1512045
27379201	2056	2065	low doses	T061	C1518010
27379201	2093	2098	doses	T081	C4019308
27379201	2125	2133	clinical	T080	C0205210
27379201	2134	2146	implications	T078	C3146298
27379201	2150	2171	IR-induced DNA damage	T049	C1514688
27379201	2188	2191	CAs	T049	C0008625
27379201	2196	2215	genomic instability	T049	C0919532
27379201	2225	2236	significant	T078	C0750502
27379201	2237	2245	cellular	T025	C0007634
27379201	2246	2258	consequences	T169	C0686907
27379201	2287	2295	profound	T080	C0439808
27379201	2296	2308	implications	T078	C3146298
27379201	2313	2322	long-term	T079	C0443252
27379201	2323	2335	human health	T033	C4035943
27379201	2342	2353	IR exposure	T037	C0479513
27379201	2380	2397	secondary cancers	T191	C0027627
27379201	2408	2434	pathobiological conditions	T169	C0205469
27379201	2441	2453	radiotherapy	T061	C1522449